Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-12-16
1995-04-25
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 57, 514159, 514263, 514289, 514317, 514327, 514359, 514570, 514777, 514781, 514782, 514819, 514849, 514850, 514853, 514854, 514855, 514974, A61K 910, A61K 31715, A61K 4736, A61K 4738
Patent
active
054099072
ABSTRACT:
The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and microcrystalline cellulose; an effective amount of taste masking compositions; and water, as well as a process for producing such aqueous pharmaceutical suspensions.
REFERENCES:
patent: 3539365 (1967-02-01), Duran et al.
patent: 4145440 (1977-08-01), Fitch et al.
patent: 4198390 (1980-04-01), Rider
patent: 4327076 (1982-04-01), Puglia et al.
patent: 4361580 (1982-05-01), Peck et al.
patent: 4427681 (1984-01-01), Munshi
patent: 4711774 (1987-12-01), Denick et al.
patent: 4716033 (1987-12-01), Denick
patent: 4717565 (1987-03-01), Denick
patent: 4761274 (1987-10-01), Denick et al.
patent: 4766216 (1988-08-01), Wright
patent: 4772724 (1988-09-01), Wright et al.
patent: 4788220 (1988-11-01), Mody et al.
patent: 4822876 (1989-04-01), Wright et al.
patent: 4857324 (1989-08-01), Mir et al.
patent: 4882324 (1989-11-01), Wright et al.
patent: 4886669 (1989-12-01), Ventouras
patent: 4895723 (1990-01-01), Amer et al.
patent: 4923981 (1990-05-01), Weibel et al.
patent: 4975465 (1990-12-01), Motola et al.
patent: 4996222 (1991-02-01), Carlia et al.
patent: 5013557 (1991-05-01), Tai
patent: 5019591 (1991-05-01), Gardner et al.
patent: 5024997 (1991-06-01), Motola et al.
patent: 5032393 (1991-07-01), Douglas et al.
patent: 5107842 (1992-04-01), Levene et al.
patent: 5112604 (1992-05-01), Beaurline et al.
patent: 5167964 (1992-12-01), Muhammad et al.
patent: 5173305 (1992-12-01), Grimberg
patent: 5196436 (1993-03-01), Smith
patent: 5272137 (1993-12-01), Blase
patent: 5281408 (1994-01-01), Unger
Remington's Pharmaceutical Sciences, 18th Ed., Chapter 83, Solution's, Emulsions, Suspensions and Extracts, pp. 1519-1530 (1990).
Avicel.RTM. RC/CL Microcrystalline Cellulose and Carboxymethyl Cellulose, NF, Bulletin RC-16, FMC Corp., pp. 1-8 (1986).
Chemical Abstracts, vol. 104, No. 8, Abst. II 104:52267c, pp. 79-80, Feb. 1986.
Avicel.RTM.RC-591 Microcrystalline Cellulose in Emulsions and Suspensions, FMC Corp. (1983).
DiMemo, L. M. et al., "Rheological and Colloidal Aspects of Avicel.RTM. Microcrystalline Cellulose", Cellulose its Derivative, chapter 47, pp. 511-519 (1985).
Remington's Pharmaceutical Sciences, 16th Ed., p. 1247 (1980).
Handbook of Pharmaceutical Excipients, pp. 131-133 (1986).
The Physicians Desk Reference, 46th Ed., pp. 1156-1157 (1992).
Blase Cynthia M.
Shah Manoj N.
Griffin Ronald W.
Mc-Neil-PPC, Inc.
Plantz Bernard F.
LandOfFree
Aqueous pharmaceutical suspension for pharmaceutical actives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aqueous pharmaceutical suspension for pharmaceutical actives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous pharmaceutical suspension for pharmaceutical actives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1567749